GLP-1 medications are prescription treatments and are not suitable for everyone. Compounded semaglutide and tirzepatide are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality. Eligibility for treatment is determined by a licensed healthcare provider following completion of the medical intake. Individual results may vary and weight loss is not guaranteed.